AdvanSix Inc.
Rank #423ValueASIX · NYSE · Basic Materials
AdvanSix Inc. (ASIX) — Rank #423 by gross profitability (GP/assets 0.10) · ROE 6.2% · Piotroski F-Score N/A.
As-of 2026-09-28 · CIK 0001673985 · all metrics point-in-time as of the filing date.
About
AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally.
Show moreShow less
The company offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. It also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and resins. In addition, the company offers intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines; and cyclohexanol, sulfuric acid, ammonia, and carbon dioxide, as well as automotive components, water treatment, and pharmaceutical intermediates. It offers its products under the Aegis, Sulf-N, Nadone, Naxol, and EZ-Blox under brand names. The company sells its products directly and through distributors. AdvanSix Inc.
was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
- Industry
- Chemicals
- Sector
- Basic Materials
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- advansix.com
Financials
Weakening
Direction over 5 fiscal years
- Free cash flowdeteriorating
- Gross margindeteriorating
- Gross profitabilitydeteriorating
- Net cashimproving
- Operating marginn/a
- Return on equitydeteriorating
- Share count (dilution)improving
Red flags: fcf_ni_divergence_unfavorable
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-02-20 | 2024-12-31filed 2025-02-21 | 2023-12-31filed 2024-02-16 | 2022-12-31filed 2023-02-17 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 1,522.2 | 1,517.6 | 1,533.6 | 1,945.6 |
| Revenue growth (YoY) | 0.3% | -1.0% | -21.2% | 15.5% |
| Gross profit | 164.9 | 152.9 | 165.1 | 314.5 |
| Gross margin | 10.8% | 10.1% | 10.8% | 16.2% |
| Net income | 49.3 | 44.1 | 54.6 | 171.9 |
| Net margin | 3.2% | 2.9% | 3.6% | 8.8% |
| EPS (diluted) | $1.80 | $1.62 | $1.95 | $5.92 |
| EPS growth (YoY) | 11.1% | -16.9% | -67.1% | — |
| Cash flow | ||||
| Operating cash flow | 122.9 | 135.4 | 117.6 | 273.6 |
| Capital expenditures | 116.4 | 133.7 | 107.4 | 89.4 |
| Free cash flow | 6.4 | 1.7 | 10.2 | 184.2 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?